Literature DB >> 29143519

Advanced Non–Small-Cell Lung Cancer.

Sukhwinder S Sohal1,2, Eugene H Walters1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29143519     DOI： 10.1056/NEJMc1712794

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

2.  Epithelial-mesenchymal transition is driven by transcriptional and post transcriptional modulations in COPD: implications for disease progression and new therapeutics.

Authors:  Mathew Suji Eapen; Pawan Sharma; Archana Vijay Gaikwad; Wenying Lu; Stephen Myers; Philip M Hansbro; Sukhwinder Singh Sohal
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-07-18

3.  microRNAs Are Key Regulators in Chronic Lung Disease: Exploring the Vital Link between Disease Progression and Lung Cancer.

Authors:  Mathew Suji Eapen; Kielan Darcy McAlinden; Stephen Myers; Wenying Lu; Sukhwinder Singh Sohal
Journal:  J Clin Med       Date:  2019-11-15       Impact factor: 4.964

4.  Inhaled corticosteroids and risk of lung cancer among chronic obstructive pulmonary disease patients: a comprehensive analysis of nine prospective cohorts.

Authors:  Fan Ge; Yi Feng; Zhenyu Huo; Caichen Li; Runchen Wang; Yaokai Wen; Sirui Gao; Haoxin Peng; Xiangrong Wu; Hengrui Liang; Bo Cheng; Ran Zhong; Jianxing He; Wenhua Liang
Journal:  Transl Lung Cancer Res       Date:  2021-03

5.  Astragaloside IV Inhibits the Progression of Non-Small Cell Lung Cancer Through the Akt/GSK-3β/β-Catenin Pathway.

Authors:  Liwei Jia; Dongying Lv; Shuang Zhang; Zhenyue Wang; Bo Zhou
Journal:  Oncol Res       Date:  2018-08-21       Impact factor: 4.938

6.  Therapeutic Modalities for Asthma, COPD, and Pathogenesis of COVID-19: Insights from the Special Issue.

Authors:  Sukhwinder Singh Sohal
Journal:  J Clin Med       Date:  2022-08-03       Impact factor: 4.964
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.